The relationship between hypoxia-inducible factor 1α (HIF-1α) and patient survival in breast cancer: systematic review and meta-analysis

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

(2019) Xinming Jing et al.   Molecular Cancer

Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer

(2019) Annika Jögi et al.   PLoS One

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

(2018) Gregory P. Kalemkerian et al.   JOURNAL OF CLINICAL ONCOLOGY

The hypoxic tumour microenvironment

(2018) Varvara Petrova et al.   Oncogenesis

Hypoxia-Inducible Factor 1α Regulates the Transforming Growth Factor β1/SMAD Family Member 3 Pathway to Promote Breast Cancer Progression

(2018) Jianheng Peng et al.   Journal of Breast Cancer

Hypoxia-inducible factor 1-alpha expression correlates with response to neoadjuvant chemotherapy in women with breast cancer

(2018) Caiyun Nie et al.   MEDICINE

FBP1 expression is associated with basal-like breast carcinoma

(2017) Lei Shi et al.   Oncology Letters

The prognostic role of tumor size in early breast cancer in the era of molecular biology

(2017) Anaid Anna Kasangian et al.   PLoS One

Role of Intestinal HIF-2α in Health and Disease

(2016) Sadeesh K. Ramakrishnan et al.   Annual Review of Physiology

The hypoxic tumor microenvironment: A driving force for breast cancer progression

(2016) Gregg L. Semenza   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Hypoxic tumor microenvironment: Opportunities to develop targeted therapies

(2016) Akhil Patel et al.   BIOTECHNOLOGY ADVANCES

Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth

(2016) Min Li et al.   ONCOLOGY REPORTS

Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer

(2016) Hawa Nalwoga et al.   PLoS One

Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer

(2016) Min-Sun Jin et al.   VIRCHOWS ARCHIV

Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer

(2016) Feng-Feng Cai et al.   Oncotarget

Hypoxia-inducible factor 1 and breast cancer metastasis

(2015) Zhao-ji Liu et al.   Journal of Zhejiang University-SCIENCE B

Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma

(2015) Arvydas Laurinavicius et al.   Oncotarget

SNP 1772 C > T of HIF-1α gene associates with breast cancer risk in a Taiwanese population

(2014) Chih-Jen Huang et al.   Cancer Cell International

Hypoxia-inducible factor 1α in breast cancer prognosis

(2013) Wei Wang et al.   CLINICA CHIMICA ACTA

Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer

(2013) Min Dong et al.   MEDICAL ONCOLOGY

The Prognostic Importance of Nuclear Factor κB and Hypoxia-inducible Factor 1α in Relation to the Breast Cancer Subtype and the Overall Survival

(2013) Koraljka Rajković-Molek et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis

(2012) Andrea Malfettone et al.   BMC CANCER

Tumour size predicts long-term survival among women with lymph node-positive breast cancer

(2012) S.A. Narod   Current Oncology

Anti-angiogenic and anti-tumor activity of Bavachinin by targeting hypoxia-inducible factor-1α

(2012) Manoj Nepal et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Over-Expression of Semaphorin4D, Hypoxia-Inducible Factor-1α; and Vascular Endothelial Growth Factor Is Related to Poor Prognosis in Ovarian Epithelial Cancer

(2012) Ying Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Hypoxia-Inducible Factor-1α and Excision Repair Cross-Complementing 1 in Patients with Small Cell Lung Cancer Who Received Front-Line Platinum-Based Chemotherapy: A Retrospective Study

(2012) Gyeong-Won Lee et al.   Journal of Thoracic Oncology

Metabolism-Related Proteins Are Differentially Expressed according to the Molecular Subtype of Invasive Breast Cancer Defined by Surrogate Immunohistochemistry

(2012) Junjeong Choi et al.   PATHOBIOLOGY

Hypoxia-related molecules HIF-1α, CA9, and osteopontin

(2012) O.P. Erpolat et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients

(2011) Emmi Peurala et al.   BREAST CANCER RESEARCH AND TREATMENT

Alteration of REDD1-Mediated Mammalian Target of Rapamycin Pathway and Hypoxia-Inducible Factor-1α Regulation in Human Breast Cancer

(2011) Ja Seung Koo et al.   PATHOBIOLOGY

Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery

(2009) Chen-Xin Dai et al.   BMC CANCER

BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression

(2009) M Yan et al.   BRITISH JOURNAL OF CANCER